Monday, May 19, 2014

The Motley Fool: 4th Time Not (Yet) the Charm for Pfizer

Pfizer (NYSE: PFE  ) is certainly not letting AstraZeneca (NYSE: AZN  ) slip away without a good fight. While Pfizer has been on a charm offense on both sides of the ocean trying to convince politicians that the deal is a legitimate business combination and not a cost-cutting tax dodge, the company has also stepped up its financial consideration to AstraZeneca shareholders. With AstraZeneca's board rejecting the latest and according to Pfizer the "final" offer, it remains to be seen if the international charm offensive can win over enough AstraZeneca shareholders to lead them to put pressure on their board to come to the negotiating table.

Read the full article here:
4th Time Not (Yet) the Charm for Pfizer

No comments: